Structure-activity relationship studies of the tricyclic indoline resistance-modifying agent

Journal of Medicinal Chemistry

Volumn 57, Issue 9, 2014, Pages 3803-3817

  Chang, Le ^a   Podoll, Jessica D ^a   Wang, Wei ^a   Walls, Shane ^a   Orourke, Courtney P ^a   Wang, Xiang ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; INDOLE DERIVATIVE; MEROPENEM; N [2 (6 BROMO 4 METHYLIDENE 2,3,4,4A,9,9A HEXAHYDRO 1H CARBAZOL 4A YL)ETHYL] 4 CHLOROBENZENE 1 SULFONAMIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

ANTI-BACTERIAL AGENTS; CARBAZOLES; DRUG RESISTANCE, MICROBIAL; HELA CELLS; HEMOLYSIS; HUMANS; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 84900317459     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm500146g     Document Type: Article

References (26)

1. Payne, D. J. Microbiology. Desperately seeking new antibiotics Science 2008, 321, 1644-1645
2. Lewis, K. Platforms for antibiotic discovery Nat. Rev. Drug Discovery 2013, 12, 371-387
3. Coates, A. R. M.; Halls, G.; Hu, Y. Novel classes of antibiotics or more of the same? Br. J. Pharmacol. 2011, 163, 184-194
4. Lowy, F. D. Antimicrobial resistance: The example of Staphylococcus aureus J. Clin. Invest. 2003, 111, 1265-1273
5. Stryjewski, M. E.; Corey, G. R. Methicillin-resistant Staphylococcus aureus: An evolving pathogen Clin. Infect. Dis. 2014, 58, 10-19
6. Cohen, M. L. Epidemiology of drug resistance: Implications for a post-antimicrobial era Science 1992, 257, 1050-1055
7. Center for Disease Control and Prevention. Antibiotic Resistance Threats; CDC: Atlanta, GA, 2013.
8. Bal, A. M.; Garau, J.; Gould, I. M.; Liao, C. H.; Mazzei, T.; Nimmo, G. R.; Soriano, A.; Stefani, S.; Tenover, F. C. Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era? J. Glob. Antimicrob. Resist. 2013, 1, 23-30
9. Abreu, A. C.; McBain, A. J.; Simoes, M. Plants as sources of new antimicrobials and resistance-modifying agents Nat. Prod. Rep. 2012, 29, 1007-1021
10. Reading, C.; Cole, M. Clavulanic acid: A beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus Antimicrob. Agents Chemother. 1977, 11, 852-857
11. Rossolini, G. M. Acquired metallo-beta-lactamases: An increasing clinical threat Clin. Infect. Dis. 2005, 41, 1557-1558
12. Worthington, R. J.; Melander, C. Overcoming resistance to β-lactam antibiotics J. Org. Chem. 2013, 78, 4207-4213
13. Worthington, R. J.; Richards, J. J.; Melander, C. Small molecule control of bacterial biofilms Org. Biomol. Chem. 2012, 10, 7457-7474
14. Wang, H.; Gill, C. J.; Lee, S. H.; Mann, P.; Zuck, P.; Meredith, T. C.; Murgolo; She, X.; Kales, S.; Liang, L.; Liu, J.; Wu, J.; Maria, J. S.; Su, J.; Pan, J.; Hailey, J.; Mcguiness, D.; Tan, C. M.; Flattery, A.; Walker, S.; Black, T.; Roemer, T. Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents Chem. Biol. 2013, 20, 272-284
15. Pasquina, L. W.; Santa Maria, J. P.; Walker, S. Teichoic acid biosynthesis as an antibiotic target Curr. Opin. Microbiol. 2013, 16, 531-537
16. Podoll, J. D.; Liu, Y.; Chang, L.; Wall, S.; Wang, W.; Wang, X. Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 15573-15578
17. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement; CLSI: Wayne, PA, 2007.
18. Yeo, S. J.; Liu, Y.; Wang, X. A one-pot three-component reaction for the preparation of highly functionalized tryptamines Tetrahedron 2012, 68, 813-818
19. Liu, Y.; Xu, W.; Wang, X. Gold(I)-catalyzed tandem cyclization approach to tetracyclic indolines Org. Lett. 2010, 12, 1448-1451
20. Sanchez, I. H.; Lopez, F. J.; Soria, J. J.; Larraza, M. I.; Flores, H. J. Total synthesis of (±)-elwesine, (±)-epielwesine, and (±)-oxocrinine J. Am. Chem. Soc. 1983, 105, 7640-7643
21. Wu, C.; Decker, E. R.; Blok, N.; Bui, H.; You, T. J.; Wang, J.; Bourgoyne, A. R.; Knowles, V.; Berens, K.; Holland, G. W.; Brock, T. A.; Dixon, R. A. F. Discovery, modeling, and human pharmacokinetics of N -(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl) thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonist J. Med. Chem. 2004, 47, 1969-1986
22. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Amntimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard; CLSI: Wayne, PA, 2009.
23. Sopirala, M. M.; Mangino, J. E.; gebreyes, W. A.; Beller, B.; Bannerman, T.; Balada-Llasat, J. M.; Pancholi, P. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii Antimicrob. Agents Chemother. 2010, 54, 4678-4683
24. Meng, H.; Kumar, K. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids J. Am. Chem. Soc. 2007, 129, 15615-15622
25. Wang, F.; Qin, L.; Pace, C. J.; Malonis, R.; Gao, J. Solubilized gramicidin A as potential systemic antibiotics ChemBioChem 2012, 13, 51-55
26. Wright, G. D. The antibiotic resistome: The nexus of chemical and genetic diversity Nat. Rev. Microbiol. 2007, 5, 175-186